The role of lipopolysaccharide in T-cell responses following DNA vaccination

Vaccine

Volumn 21, Issue 13-14, 2003, Pages 1548-1553

  Hawkins, William G ^a   Trcka, Jiri ^a   Segal, Neil ^a   Blachere, Nathalie E ^a   Gold, Jason S ^a   Moroi, Yoichi ^a   Bowne, Wilbur B ^a   Lewis, Jonathan J ^a   Wolchok, Jedd D ^a   Houghton, Alan N ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

DNA vaccination; Lipopolysaccharide; T cell immunity

Indexed keywords

CD8 ANTIGEN; DNA VACCINE; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STRAIN DIFFERENCE; T LYMPHOCYTE; VACCINATION; VACCINATION REACTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; VACCINATION; VACCINES, DNA;

EID: 0037471394     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00676-X     Document Type: Article

References (22)

1. + T cells after gene gun immunization. J. Exp. Med. 188:1998;1075-1082.
2. Akbari O., Panjwani N., Garcia S.et al. DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J. Exp. Med. 189:1999;169-178.
3. Klinman D.M., Ishii K.J., Verthelyi D. CpG DNA augments the immunogenicity of plasmid DNA vaccines. Curr. Top. Microbiol. Immunol. 247:2000;131-142.
4. Wicks I.P., Howell M.L., Hancock T.et al. Bacterial lipopolysaccharide copurifies with plasmid DNA: implications for animal models and human gene therapy. Hum. Gene Ther. 6:1995;317-323.
5. Sato Y., Roman M., Tighe H.et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352-354.
6. O'Neill L. Specificity in the innate response: pathogen recognition by Toll-like receptor combinations. Trends Immunol. 22:2001;70-93.
7. Poltorak A., He X., Smirnova I.et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
8. Qureshi S.T., Lariviere L., Leveque G.et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:1999;615-625.
9. Wang Q., Dziarski R., Kirschning C.J.et al. Micrococci and peptidoglycan activate TLR2 → MyD88 → IRAK → TRAF → NIK → IKK → NF-kappaB signal transduction pathway that induces transcription of interleukin-8. Infect. Immun. 69:2001;2270-2276.
10. Tapping R.I., Akashi S., Miyake K.et al. Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J. Immunol. 165:2000;5780-5787.
11. Hemmi H., Takeuchi O., Kawai T.et al. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745.
12. Granucci F., Ferrero E., Foti M.et al. Early events in dendritic cell maturation induced by LPS. Microbes Infect. 1:1999;1079-1084.
13. Ross H.M., Weber L.W., Wang S.et al. Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization. Clin. Cancer Res. 3:1997;2191-2196.
14. Lewis J.J., Janetzki S., Schaed S.et al. Evaluation of CD8+ T cell Frequencies by the ELISPOT assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide. Int. J. Cancer. 87:2000;391-398.
15. Inaba K., Inaba M., Romani N.et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1992;1693-1702.
16. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5:1999;1249-1255.
17. Suri R.M., Austyn J.M. Bacterial lipopolysaccharide contamination of commercial collagen preparations may mediate dendritic cell maturation in culture. J. Immunol. Methods. 214:1998;149-163.
18. Sasaki S., Tsuji T., Hamajima K.et al. Monophosphoryl lipid A 2 enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1. Infect. Immun. 65:1997;3520-3528.
19. Boyle J.S., Brady J.L., Koniaras C.et al. Inhibitory effect of lipopolysaccharide on immune response after DNA immunization is route dependent. DNA Cell Biol. 17:1998;343-348.
20. Sasaki S., Hamajima K., Fukushima J.et al. Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type I with a DNA-monophosphoryl lipid A adjutant vaccine. Infect. Immun. 66:1998;823-826.
21. Lodmell D.L., Ray N.B., Ulrich J.T., Ewalt L.C. DNA vaccination of mice against rabies virus: effects of route of vaccination and the adjutant monophosphoryl lipid A. Vaccine. 18:2000;1059-1066.
22. Castro A., Bemer V., Nobrega A.et al. Administration to mouse of endotoxin from gram-negative bacteria leads to activation and apoptosis of T lymphocytes. Eur. J. Immunol. 28:1998;488-495.